RT Journal Article
SR Electronic
T1 Ovarian follicular function is not altered by SARS-Cov-2 infection or BNT162b2 mRNA Covid-19 vaccination
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.09.21255195
DO 10.1101/2021.04.09.21255195
A1 Bentov, Yaakov
A1 Beharier, Ofer
A1 Moav-Zafrir, Arbel
A1 Kabessa, Maor
A1 Godin, Miri
A1 Greenfield, Caryn S.
A1 Ketzinel-Gilad, Mali
A1 Broder, Efrat Esh
A1 Holzer, Hananel E. G.
A1 Wolf, Dana
A1 Oiknine-Djian, Esther
A1 Barghouti, Iyad
A1 Goldman-Wohl, Debra
A1 Yagel, Simcha
A1 Walfisch, Asnat
A1 Klement, Anat Hersko
YR 2021
UL http://medrxiv.org/content/early/2021/04/13/2021.04.09.21255195.abstract
AB Importance This is the first study to examine the impact of SARS-Cov-2 infection and COVID-19 vaccination on ovarian function.Objective To characterize anti-COVID-19 antibodies in follicular fluid and compare ovarian follicle function in women following confirmed SARS-CoV-2 infection, COVID-19 vaccination, and non-infected, unvaccinated controls.Design This is a cohort study conducted between February 1 and March 10, 2021.Setting A single university hospital-based IVF clinic.Participants Consecutive sample of female patients undergoing oocyte retrieval.Interventions Consenting patients were recruited and assigned to one of three study groups: recovering from confirmed COVID 19 (n=9); vaccinated (n=9); and uninfected, non-vaccinated controls (n=14). Serum and follicular fluid samples were taken and analyzed for anti-COVID IgG as well as estrogen, progesterone and HSPG2 concentration, as well as the number and maturity of aspirated oocytes and previous estrogen and progesterone measurements.Main outcome measures Follicular function, including steroidogenesis, follicular response to the LH/hCG trigger, and oocyte quality biomarkers.Results Both natural and vaccine elicited anti-COVID IgG antibodies were detected in the follicular fluid in levels proportional to the IgG serum concentration. No differences were detected in any of the surrogate ovarian follicle quality reporting parameters.Conclusions and relevance Both SARS-COV-2 infection and vaccination with the BNT162b2 mRNA vaccine mediate IgG immunity that crosses into the follicular fluid. No detrimental effect on follicular function was detected.Trial Registration CinicalTrials.gov registry number NCT04822012Key Point COVID 19 disease and BNT162b2 mRNA vaccine induce anti-COVID IgG in follicular fluid; neither recent infection nor vaccination appear to negatively effect follicular function.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04822012Funding StatementNon fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Hadassah Medical Center IRB (Permit 0053-21-HMO).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available upon a reasonable request